Accordingly, while studies have shown that CCL18 plays a role in fibrotic interstitial lung disease [25,27], higher CCL18 levels have been observed in lung diseases with a prominent lymphocytic inflammatory component, such as sarcoidosis [28]. Here, CCL18 is linked to interstitial lung disease.